Unichem Laboratories Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Pabitra Kumar Bhattacharya
Algemeen directeur
₹29.2m
Totale compensatie
| Percentage CEO-salaris | 64.3% |
| Dienstverband CEO | 1.3yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 12.3yrs |
| Gemiddelde ambtstermijn bestuur | 1.3yrs |
Recente managementupdates
Recent updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02
It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23
Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -₹56m |
| Jun 30 2024 | n/a | n/a | -₹606m |
| Mar 31 2024 | ₹29m | ₹19m | -₹705m |
Compensatie versus markt: De totale vergoeding ($USD 345.49K ) Pabitra Kumar } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 355.26K ).
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Pabitra Kumar te vergelijken met de prestaties van het bedrijf.
CEO
Pabitra Kumar Bhattacharya (55 yo)
1.3yrs
Tenure
₹29,175,000
Compensatie
Mr. Pabitra Kumar Kalipada Bhattacharya had been Managing Director of Krebs Biochemicals & Industries Limited since August 1, 2021 until August 9, 2023 and had been its Additional Director since July 30, 2...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 1.3yrs | ₹29.18m | geen gegevens | |
| Head of Legal | 5.3yrs | ₹9.84m | geen gegevens | |
| Chief Scientific & Compliance Officer | no data | geen gegevens | geen gegevens | |
| Vice President of Human Resources & ER | 16.4yrs | ₹7.48m | geen gegevens | |
| Head of Projects & Investments | no data | ₹2.10m | geen gegevens | |
| Chief Quality & Compliance Officer | no data | geen gegevens | geen gegevens | |
| Chief Manufacturing & Compliance Officer | no data | geen gegevens | geen gegevens | |
| Chief Executive of Domestic Pharma | 12.3yrs | ₹13.62m | geen gegevens | |
| President of North America & CEO of North America | 6.4yrs | geen gegevens | geen gegevens | |
| Vice President of Chemical of Research and Development | no data | ₹593.35k | geen gegevens | |
| Vice President of Commercial | 24yrs | ₹6.14m | geen gegevens | |
| Advisor of Active Pharmaceutical Ingredients (API) | no data | ₹5.24m | geen gegevens |
12.3yrs
Gemiddelde duur
65.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van UNICHEMLAB is doorgewinterd en ervaren (gemiddelde ambtstermijn van 12.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 1.3yrs | ₹29.18m | geen gegevens | |
| Chairman | 50.4yrs | ₹328.40m | 16.21% ₹ 9.8b | |
| Independent Director | less than a year | ₹100.00k | geen gegevens | |
| Non-Executive Non-Independent Director | 1.3yrs | ₹300.00k | geen gegevens | |
| Additional Independent Non-Executive Director | 1.7yrs | ₹850.00k | geen gegevens | |
| Independent Director | less than a year | ₹100.00k | geen gegevens |
1.3yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van UNICHEMLAB wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw bestuur.